Anpario (LON:ANP) Upgraded by Canaccord Genuity Group to “Buy” Rating

Canaccord Genuity Group upgraded shares of Anpario (LON:ANPFree Report) to a buy rating in a report released on Thursday morning,London Stock Exchange reports. They currently have GBX 570 price objective on the stock, up from their prior price objective of GBX 457.

Separately, Shore Capital Group reaffirmed a “house stock” rating on shares of Anpario in a report on Monday, January 19th. One analyst has rated the stock with a Buy rating, Based on data from MarketBeat, the stock has an average rating of “Buy” and an average price target of GBX 570.

Check Out Our Latest Stock Report on ANP

Anpario Price Performance

Shares of LON ANP opened at GBX 460.30 on Thursday. The company has a current ratio of 4.32, a quick ratio of 5.16 and a debt-to-equity ratio of 0.22. The company’s 50-day moving average price is GBX 510.21 and its 200 day moving average price is GBX 496.50. Anpario has a 52 week low of GBX 286 and a 52 week high of GBX 580. The stock has a market cap of £78.00 million, a price-to-earnings ratio of 15.49 and a beta of 0.92.

About Anpario

(Get Free Report)

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.

Read More

Receive News & Ratings for Anpario Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anpario and related companies with MarketBeat.com's FREE daily email newsletter.